Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
Abroad (travel likely)RecruitingPHASE1
Conditions
Duchenne Muscular Dystrophy (DMD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Study leads
Larry W. Markham, MD
Principal Investigator
Vanderbilt University Medical Center